Nucevia 50 units

Nucevia 50 Units is a prescription-only botulinum toxin type A medicine supplied as a powder for solution for injection. Each vial contains 50 units and requires reconstitution before administration. Nucevia potency units are product-specific and are not interchangeable with units of other botulinum toxin preparations.

Nucevia 50 Units product information

• Product: Nucevia® 50 Units
• Active ingredient: Botulinum toxin type A
• Strength: 50 units per vial
• After reconstitution: 4 units per 0.1 ml
• Pharmaceutical form: Powder for solution for injection
• Route of administration: Intramuscular
• Legal category: Prescription-only medicine (POM)
• Marketing Authorisation Holder: Evolus

Professional pharmacy supply

Longeva Pharma supplies Nucevia to eligible UK professional customers subject to the applicable prescription requirements and pharmacist review. Browse the Botulinum Toxins & Diluents range or the Evolus collection.

Licensed indication

Nucevia is licensed for the temporary improvement in the appearance of moderate to severe vertical lines between the eyebrows (glabellar lines) at maximum frown in adults under 75 years where the severity of the facial lines has an important psychological impact. Prescribers should consult the current SmPC for the complete authorised indication and clinical information.

Reconstitution and storage

Nucevia requires reconstitution before administration. Healthcare professionals should follow the current SmPC for reconstitution, aseptic handling, dosage and administration instructions.

Store refrigerated at 2°C–8°C. Refer to the current SmPC for full storage, handling and post-reconstitution requirements.

Practitioner information

Practitioners comparing available toxin medicines can read our UK botulinum toxin brands comparison and our professional toxin supplier and ordering guide.

Professional supply only. Prescription required.

Important prescribing information

Healthcare professionals should consult the current Nucevia 50 Units Summary of Product Characteristics (SmPC) before prescribing, preparing or administering the medicine. The SmPC contains full information on contraindications, warnings and precautions, dosage, administration, adverse reactions, storage and handling.

Prescription-only medicines (POM) are always dispensed against a valid, patient-specific prescription and are never available as clinic stock, under any circumstances.

Where a product genuinely supports both routes, you choose whether you are ordering that item on prescription for a named patient or as clinic stock under your professional responsibility when you select it on the product page.

Named-patient prescription supply. Items chosen for a named patient are dispensed against your prescription. The order is held for Superintendent Pharmacist review before despatch. Prescription supply is zero-rated for VAT.

Clinic stock supply. Where eligible, items chosen as clinic stock are supplied under your professional responsibility for use in your practice. Standard VAT applies at checkout. This route is never offered for prescription-only medicines.

Orders containing prescription-only medicines are held until the Superintendent Pharmacist has cleared the prescription. Same-day dispatch applies once cleared.

For questions about prescription supply, contact admin@longevapharma.com or reply to your order confirmation email.

Delivery: Dispatch and delivery depend on stock, cleared payment, customer eligibility and any required prescription or pharmacy checks. Delivery estimates are not guarantees. See our Shipping and Delivery Policy.

Returns: Because storage history, product integrity, traceability and chain of custody cannot be verified after regulated healthcare goods leave our control, medicines, cold-chain goods, sterile products, injectables and other regulated products cannot normally be returned after dispatch. This does not affect remedies for goods supplied incorrectly, damaged or defective. See our Returns and Refunds Policy.

Cold chain: Temperature-sensitive products must be received promptly and transferred to the required storage conditions. If damage or a suspected temperature excursion is identified, quarantine the goods, retain all packaging and contact Longeva Pharma before use.